Tejiokem, M.C.; Desselas, E.; Noumsi, T.J.; Ateba Ndongo, F.; Tetang Ndiang, S.; Fossi, M.A.; Guemkam, G.; Zangue Kenfack Tekougang, B.; Tagnouokam-Ngoupo, P.A.; Penda, I.C.;
et al. Pre- and Post-Vaccination Measles Antibody and Persistence Up to 5 Years of Age Among Early ART-Treated HIV-Infected, HIV-Exposed Uninfected and HIV-Unexposed Children in Cameroon. Vaccines 2025, 13, 584.
https://doi.org/10.3390/vaccines13060584
AMA Style
Tejiokem MC, Desselas E, Noumsi TJ, Ateba Ndongo F, Tetang Ndiang S, Fossi MA, Guemkam G, Zangue Kenfack Tekougang B, Tagnouokam-Ngoupo PA, Penda IC,
et al. Pre- and Post-Vaccination Measles Antibody and Persistence Up to 5 Years of Age Among Early ART-Treated HIV-Infected, HIV-Exposed Uninfected and HIV-Unexposed Children in Cameroon. Vaccines. 2025; 13(6):584.
https://doi.org/10.3390/vaccines13060584
Chicago/Turabian Style
Tejiokem, Mathurin Cyrille, Emilie Desselas, Thierry Joel Noumsi, Francis Ateba Ndongo, Suzie Tetang Ndiang, Mireille Arlette Fossi, Georgette Guemkam, Berenice Zangue Kenfack Tekougang, Paul Alain Tagnouokam-Ngoupo, Ida Calixte Penda,
and et al. 2025. "Pre- and Post-Vaccination Measles Antibody and Persistence Up to 5 Years of Age Among Early ART-Treated HIV-Infected, HIV-Exposed Uninfected and HIV-Unexposed Children in Cameroon" Vaccines 13, no. 6: 584.
https://doi.org/10.3390/vaccines13060584
APA Style
Tejiokem, M. C., Desselas, E., Noumsi, T. J., Ateba Ndongo, F., Tetang Ndiang, S., Fossi, M. A., Guemkam, G., Zangue Kenfack Tekougang, B., Tagnouokam-Ngoupo, P. A., Penda, I. C., Faye, A., & Warszawski, J.
(2025). Pre- and Post-Vaccination Measles Antibody and Persistence Up to 5 Years of Age Among Early ART-Treated HIV-Infected, HIV-Exposed Uninfected and HIV-Unexposed Children in Cameroon. Vaccines, 13(6), 584.
https://doi.org/10.3390/vaccines13060584
